Trials / Completed
CompletedNCT06625736
Anti-obesity Effects of Dandelion (Taraxacum Officinale L.)
Anti-obesity Effects of Dandelion (Taraxacum Officinale L.) in Premenopausal Obese Women: Impacts on Appetite, Energy Intake and Lipid Metabolism
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- October 6 University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
The study investigates the effectiveness of the natural product Dandelion in treating obesity in premenopausal women through a randomized interventional trial, measuring various parameters and biomarkers.
Detailed description
The study aims to explore the anti-obesity effects of dandelion supplementation in premenopausal obese women. The research will measure changes in appetite, energy intake, body weight, composition, lipid profile, and inflammatory markers, providing evidence of dandelion\'s efficacy as an anti-obesity phototherapy. The randomized interventional trial will measure multiple parameters and biomarkers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Xenical | The Xenical group will receive identical capsules 120mg (one capsule) to be taken three times daily with meals, equaling 360mg total daily dose, which aligns with the usage in adult female patients |
| DIETARY_SUPPLEMENT | The dandelion extract | The dandelion extract group will receive 500 mg capsules of dandelion leaf extract, given 3 times per day before meals. |
Timeline
- Start date
- 2024-01-05
- Primary completion
- 2024-09-07
- Completion
- 2024-09-07
- First posted
- 2024-10-03
- Last updated
- 2024-10-03
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06625736. Inclusion in this directory is not an endorsement.